The effect of obesity on chronic respiratory diseases: Pathophysiology and therapeutic strategies

CMAJ. Canadian Medical Association Journal

Volumn 174, Issue 9, 2006, Pages 1293-1299

  Poulain, Magali ^a,b   Doucet, Mariève ^b   Major, Geneviève C ^a   Drapeau, Vicky ^a   Sériès, Frédéric ^b   Boulet, Louis Philippe ^b   Tremblay, Angelo ^a   Maltais, François ^b,c  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; DIET; DISEASE ASSOCIATION; ETHNOLOGY; EXERCISE; HUMAN; INDUSTRIALIZATION; LIFESTYLE; OBESITY; OBESITY HYPOVENTILATION SYNDROME; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; POLLUTION; PREVALENCE; RESPIRATORY FUNCTION; REVIEW; RISK FACTOR; SITTING; SLEEP APNEA SYNDROME; WEIGHT REDUCTION; BODY COMPOSITION; CHRONIC DISEASE; RESPIRATORY TRACT DISEASE;

ASTHMA; BODY COMPOSITION; CHRONIC DISEASE; HUMANS; OBESITY; OBESITY HYPOVENTILATION SYNDROME; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT DISEASES; SLEEP APNEA, OBSTRUCTIVE; WEIGHT LOSS;

EID: 33645975847     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.051299     Document Type: Review

References (91)

1. International obesity taskforce [IOTF]. Available: www.iotf.org/indes.asp (accessed 20 Mar 2006).
2. Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States, 2000. JAMA 2004;291:1238-45.
3. Conway B, Rene A. Obesity as a disease: no lightweight matter. Obes Rev 2004;5:145-51.
4. Katzmarzyk PT, Craig CL, Bouchard C. Original article underweight, overweight and obesity: relationships with mortality in the 13-year follow-up of the Canada Fitness Survey. J Clin Epidemiol 2001;54:916-20.
5. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - The Evidence Report. National Institutes of Healt. Obes Res 1998;6(Suppl 2):51S-209S.
6. Shinohara E, Kihara S, Yamashita S, et al. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 1997;241:11-8.
7. Lazarus R, Sparrow D, Weiss ST. Effects of obesity and fat distribution on ventilatory function: the normative aging study. Chest 1997;111:891-8.
8. Després JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 2001;322:716-20.
9. Douketis JD. Body weight classification. CMAJ 2005;172:1274-5.
10. Chinn DJ, Cotes JE, Reed JW. Longitudinal effects of change in body mass on measurements of ventilatory capacity. Thorax 1996;51:699-704.
11. Inselma LS, Milanese A, Deurloo A. Effect of obesity on pulmonary function in children. Pediatr Pulmonol 1993;16:130-7.
12. Rubinstein I, Zamel N, DuBarry L, et al. Airflow limitation in morbidly obese, non-smoking men. Ann Intern Med 1990;112:828-32.
13. Ray CS, Sue DY, Bray G, et al. Effects of obesity on respiratory function. Am Rev Respir Dis 1983;128:501-6.
14. Biring MS, Lewis MI, Liu JT, et al. Pulmonary physiologic changes of morbid obesity. Am J Med Sci 1999;318:293-7.
15. Canoy D, Luben R, Welch A, et al. Abdominal obesity and respiratory function in men and women in the EPIC-Norfolk Study, United Kingdom. Am J Epidemiol 2004;159:1140-9.
16. Sin DD, Jones RL, Man SF. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med 2002;162:1477-81.
17. Weiner P, Waizman J, Weiner M, et al. Influence of excessive weight after gastroplasty for morbid obesity on respiratory muscle performance. Thorax 1998;53:39-42.
18. Chlif M, Keochkerian D, Mourlhon C, et al. Noninvasive assessment of the tension-time index of inspiratory muscles at rest in obese male subjects. Int J Obes (Lond) 2005;29:1478-83.
19. Norman AC, Drinkard B, McDuffie JR, et al. Influence of excess adiposity on exercise fitness and performance in overweight children and adolescents. Pediatrics 2005;115:e690-6.
20. Sharp JT, Henry JP, Sweany SK, et al. The total work of breathing in normal and obese men. J Appl Physiol 1964;43:728-39.
21. LeBlanc P, Bowie DM, Summers E, et al. Breathlessness and exercise in patients with cardiopulmonary disease. Am Rev Respir Dis 1986;133:21-5.
22. Global Initiative for Chronic Obstructive Lung Disease. Workshop report, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. September 2005. Available: www.goldcopd.org/Guidelineitem.asp?l1=2&l2=1&intId=989 (accessed 2006 Mar 20).
23. Wilson DO, Rogers RM, Wright EC, et al. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989;139:1435-8.
24. Marquis K, Debigaré R, LeBlanc P, et al. Mid-thigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with COPD. Am J Respir Crit Care Med 2002;166:809-13.
25. Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:367-70.
26. Guerra S, Sherrill DL, Bobadilla A, et al. The relation of body mass index to asthma, chronic bronchitis, and emphysema. Chest 2002;122:1256-63.
27. Pitta F, Troosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:972-7.
28. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12.
29. Schols AMW, Slangen J, Volovics L, et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1791-7.
30. Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen city heart study. Am J Respir Crit Care Med 2006;173:79-83.
31. Curtis JP, Selter JG, Wang Y, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005;165:55-61.
32. Schols AMWJ, Soeters PB, Dingemans MC, et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993;147:1151-6.
33. Schols AM, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005;82:53-9.
34. Hole DJ, Watt GC, Vey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996;313:711-5.
35. Sin DD, Man SFP. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107:1514-9.
36. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-200.
37. Somerville SM, Rona RJ, Chinn S. Obesity and respiratory symptoms in primary school. Arch Dis Child 1984;59:940-4.
38. Chinn S, Rona RJ. Can the increase in body mass index explain the rising trend in asthma in children? Thorax 2001;56:845-50.
39. Weiss ST, Shore S. Obesity and asthma: directions for research. Am J Respir Crit Care Med 2004;169:963-8.
40. Shaheen SO, Sterne JA, Montgomery SM, et al. Birth weight, body mass index and asthma in young adults. Thorax 1999;54:396-402.
41. Camargo CA Jr., Weiss ST, Zhang S, et al. Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med 1999;159:2582-8.
42. Tantisira KG, Weiss ST. Complex interactions in complex traits: obesity and asthma. Thorax 2001;56(Suppl 2):ii64-73.
43. Gilliland FD, Berhane K, Islam T, et al. Obesity and the risk of newly diagnosed asthma in school-age children. Am J Epidemiol 2003;158:406-15.
44. Guerra S, Wright AL, Morgan WJ, et al. Persistence of asthma symptoms during adolescence: role of obesity and age at the onset of puberty. Am J Respir Crit Care Med 2004;170:78-85.
45. Lavoie KL, Bacon SL, Labrecque M, et al. Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med 2005.
46. Schaub B. von ME. Obesity and asthma, what are the links? Curr Opin Allergy Clin Immunol 2005;5:185-93.
47. Schachter LM, Salome CM, Peat JK, et al. Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness. Thorax 2001;56:4-8.
48. Hakala K, Stenius-Aarniala B, Sovijarvi A. Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma. Chest 2000;118:1315-21.
49. Boulet LP, Turcotte H, Boulet G, et al. Deep inspiration avoidance and airway response to methacholine: influence of body mass index. Can Respir J 2005;12:371-6.
50. Weiss ST. Obesity; insight into the origins of asthma. Nat Immunol 2005;6:537-9.
51. Bergeron C, Boulet LP, Hamid Q. Obesity, allergy and immunology. J Allergy Clin Immunol 2005;115:1101-4.
52. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995;1:1155-61.
53. Shore SA, Fredberg JJ. Obesity, smooth muscle, and airway hyperresponsiveness. J Allergy Clin Immunol 2005;115:925-7.
54. Kim S, Camargo CA Jr. Sex-race differences in the relationship between obesity and asthma: the behavioral risk factor surveillance system, 2000. Ann Epidemiol 2003;13:666-73.
55. Aaron SD, Fergusson D, Dent R, et al. Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest 2004;125:2046-52.
56. Stenius-Aarniala B, Poussa T, Kvarnstrom J, et al. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 2000;320:827-32.
57. Simard B, Turcotte H, Marceau P, et al. Asthma and sleep apnea in patients with morbid obesity: outcome after bariatric surgery. Obes Surg 2004;14:1381-8.
58. Saint-Pierre P, Bourdin A, Chanez P, et al. Are overweight asthmatics more difficult to control? Allergy 2006;61:79-84.
59. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5.
60. Deegan PC, McNicholas WT. Pathophysiology of obstructive sleep apnoea. Eur Respir J 1995;8:1161-78.
61. Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc 2004;79:1036-46.
62. Sériès F. Upper airway muscles awake and asleep. Sleep Med Rev 2002;6:229-42.
63. Resta O, Foschino-Barbaro MP, Legari G, et al. Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord 2001;25:669-75.
64. Valencia-Flores M, Orea A, Castano VA, et al. Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients. Obes Res 2000;8:262-9.
65. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
66. Hu FB, Willett WC, Manson JE, et al. Snoring and risk of cardiovascular disease in women. J Am Coll Cardiol 2000;35:308-13.
67. Wolk R, Kara T, Somers VK. Sleep-disordered breathing and cardiovascular disease. Circulation 2003;108:9-12.
68. Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034-41.
69. The Report of an American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22:667-89.
70. Viner S, Szalai JP, Hoffstein V. Are history and physical examination a good screening test for sleep apnea? Ann Intern Med 1991;115:356-9.
71. Stoohs R, Guilleminault C. Investigations of an automatic screening device (MESAM) for obstructive sleep apnoea. Eur Respir J 1990;3:823-9.
72. Gyulay S, Olson LG, Hensley MJ, et al. A comparison of clinical assessment and home oximetry in the diagnosis of obstructive sleep apnea. Am Rev Respir Dis 1993;147:50-3.
73. Sériès F, Marc I, Cormier Y, et al. Utility of nocturnal home oximetry for case finding in patients with suspected sleep apnea hypopnea syndrome. Ann Intern Med 1993;119:449-53.
74. Flemons WW, Whitelaw WA, Brant R, et al. Likelihood ratios for a sleep apnea clinical prediction rule. Am J Respir Crit Care Med 1994;150:1279-85.
75. Noseda A, Kempenaers C, Kerkhofs M, et al. Sleep apnea after 1 year domiciliary nasal-continuous positive airway pressure and attempted weight reduction. Potential for weaning from continuous positive airway pressure. Chest 1996;109:138-43.
76. Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000;284:3015-21.
77. Sullivan CE, Issa FG, Berthon-Jones M, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981;1:862-5.
78. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men wich obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53.
79. Dursunoglu N, Dursunoglu D, Cuhadaroglu C, et al. Acute effects of automated continuous positive airway pressure on blood pressure in patients with sleep apnea and hypertension. Respiration 2005;72:150-5.
80. Veale D, Pepin JL, Wuyam B, et al. Abnormal autonomic stress responses in obstructive sleep apnoea are reversed by nasal continuous positive airway pressure. Eur Respir J 1996;9:2122-6.
81. Riley RW, Powell NB, Guilleminault C. Maxillofacial surgery and nasal CPAP. A comparison of treatment for obstructive sleep apnea syndrome. Chest 1990;98:1421-5.
82. Gotsopoulos H, Chen C, Qian J, et al. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am J Respir Crit Care Med 2002;166:743-8.
83. Herder Cd. Schmeck J, Appelboom DJK, de Vries N. Risks of general anaesthesia in people with obstructive sleep apnoea. BMJ 2004;329:955-9.
84. Bickelmann AG, Burwell CS, Robin ED, et al. Extreme obesity associated with alveolar hypoventilation; a Pickwickian syndrome. Am J Med 1956;21:811-8.
85. Kessler R, Chaouat A, Schinkewitch P, et al. The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest 2001;120:369-76.
86. Olson AL., Zwillich C. The obesity hypoventilation syndrome. Am J Med 2005;118:948-56.
87. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974;32:77-97.
88. Schols AMWJ, Wouters EFM, Soeters PB, et al. Body composition by bioelectricalimpedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991;53:421-4.
89. Pichard C, Kyle UG, Janssens JP, et al. Body composition by X-ray absorptiometry and bioelectrical impedance in chronic respiratory insufficiency patients. Nutrition 1997;13:952-8.
90. Kyle UG, Pichard C, Rochat T, et al. New bioelectrical impedance formula for patients with respiratory insufficiency: comparison to dual-energy X-ray absorptiometry. Eur Respir J 1998;12:960-6.
91. Slosman DO, Casez JP, Pichard C, et al. Assessment of whole-body composition with dual-energy x-ray absorptiometry. Radiology 1992;185:593-8.